Viewing Study NCT00005635


Ignite Creation Date: 2025-12-24 @ 10:21 PM
Ignite Modification Date: 2025-12-30 @ 9:04 PM
Study NCT ID: NCT00005635
Status: COMPLETED
Last Update Posted: 2013-08-20
First Post: 2000-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module